Sun Pharma presents data from Phase 1 studies of GL0034
GL0034 is a novel, investigational glucagon-like peptide 1 receptor agonist (GLP-1RA) being studied for the treatment of type 2 diabetes and obesity
GL0034 is a novel, investigational glucagon-like peptide 1 receptor agonist (GLP-1RA) being studied for the treatment of type 2 diabetes and obesity
This innovative product eliminates two manufacturing steps and simplifies equipment setup
Carbogen Amcis Manchester won the industry award in recognition of its efficiency improvement program implemented in response to increased demand for its products
The company will submit its comprehensive response on these observations to the USFDA
Dr. Reddy's aims to roll out its trade generics across cities and towns in India
GenWorks has scaled up its e-commerce platform in terms of building traffic
The company expects to capture a 10 per cent share in Spain’s $6.34 million meropenem market and consolidate its position in other European countries
Antimicrobial Resistance (AMR) poses a significant threat to global healthcare systems and patient safety
This product will be manufactured at Lupin's Pithampur facility in India
Effective disaster response and management is a collaborative work
Subscribe To Our Newsletter & Stay Updated